Thyroid insufficiency during pregnancy: Complications and implications for screening

Expert Review of Endocrinology and Metabolism

Volumn 3, Issue 2, 2008, Pages 137-146

  Negro, Roberto ^a  

^a VITO FAZZI HOSPITAL   (Italy)

Author keywords

Autoimmunity; Hypothyroidism; Hypothyroxinemia; Iodine; Pregnancy; Thyroid

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

AUTOIMMUNE THYROIDITIS; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HEALTH CARE COST; HIGH RISK PREGNANCY; HUMAN; HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; INTRAUTERINE GROWTH RETARDATION; IODINE DEFICIENCY; PREGNANCY COMPLICATION; PREMATURE LABOR; PRENATAL SCREENING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SCREENING TEST; SPONTANEOUS ABORTION; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST; THYROXINE BLOOD LEVEL;

EID: 55649101425     PISSN: 17446651     EISSN: None     Source Type: Journal    
DOI: 10.1586/17446651.3.2.137     Document Type: Review

References (71)

1. Abalovich M, Amino M, Barbour LA et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 92, S1-S47 (2007).
2. Casey BM, Dashe JS, Wells CE et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet. Gynecol. 105, 239-235 (2005).
3. Allan WC, Haddow JE, Palomaki GE et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J. Med. Screen. 7, 127-130 (2000).
4. Klein RZ, Haddow JE, Faix JD et al. Prevalence of thyroid deficiency in pregnant women. Clin. Endocrinol. (Oxford) 35, 41-45 (1991).
5. Davis LE, Leveno KJ, Cunningham FG. Hypothyroidism complicating pregnancy. Obstet. Gynecol. 72, 108-112 (1988).
6. Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JI. Perinatal outcome in hypothyroid pregnancies. Obstet. Gynecol. 81, 349-353 (1993).
7. Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES. Obstetric and neonatal outcomes associated with maternal hypothyroid disease. J. Matern. Fet. Neon. Med. 17, 35-38 (2005).
8. Buimer M, van Wassenaer AG, Ganzevoort W, Wolf H, Bleker OP, Kok JH. Transient hypothyroxinemia in severe hypertensive disorders of pregnancy. Obstet. Gynecol. 106, 973-979 (2005).
9. Thomas R, Reid RL. Thyroid disease and reproductive failure. Obstet. Gynecol. 70, 789-798 (1987).
10. Peterson CM. Thyroid disease and fertility. Immunol. Allergy. Clin. 14, 725-738 (1994).
11. Glinoer D, Soto MF, Bourdoux P et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J. Clin. Endocrinol. Metab. 73, 421-427 (1991).
12. Baker VL, Rone HM, Pasta DJ, Nelson HP, Gvakharia M, Adamson GD. Correlation of thyroid stimulating hormone (TSH) level with pregnancy outcome in women undergoing in vitro fertilization. Am. J. Obstet. Gynecol. 194, 1668-1674 (2006).
13. Stagnaro-Green A, Chen XH, Bogden JD, Davies TF, Scholl TO. The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid 15, 351-357 (2005).
14. Idris I, Srinivasan R, Simm A, Page R. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin. Endocrinol. (Oxford) 63, 560-565 (2005).
15. Ananth CV, Berkowitz GS, Savitz DA, Lapinski RH. Placental abruption and adverse perinatal outcomes. JAMA 282, 1646-1651 (1999).
16. Blazer S, Moreh-Waterman Y, Miller-Lotan R, Tamir A, Hochberg Z. Maternal hypothyroidism may affect fetal growth and neonatal thyroid function. Obstet. Gynecol. 102, 232-241 (2003).
17. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 12, 63-68 (2002).
18. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N. Engl. J. Med. 351, 241-249 (2004).
19. Mandel SJ, Larsen PR, Seely EW, Brent GA. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N. Engl. J. Med. 323, 91-96 (1990).
20. Kaplan MM. Monitoring thyroxine treatment during pregnancy. Thyroid 2, 147-154 (1992).
21. Panesar NS, Li CY, Rogers MS. Reference intervals for thyroid hormones in pregnant Chinese women. Ann. Clin. Biochem. 38, 329-332 (2001).
22. Kahric-Janicic N, Soldin SJ, Soldin OP, West T, Gu J, Jonklaas J. Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid 17, 303-311 (2007).
23. Skjoldebrand L, Brundin J, Calstrom A, Pettersson T. Thyroid associated components is serum during normal pregnancy. Acta Endocrinol. 100, 504-511 (1982).
24. Dafnis E, Sabatini S. The effect of pregnancy on renal function: physiology and pathophysiology. Am. J. Med. Sci. 303, 184-205 (1992).
25. Glinoer D, De Nayer P, Bourdoux P et al. Regulation of maternal thyroid during pregnancy. J. Clin. Endocrinol. Metab. 71, 276-287 (1990).
26. Ball R, Freedman DB, Holmes JC, Midgley JEM, Sheehan P. Low-normal concentrations of free thyroxin in serum in late pregnancy: physiological fact, not technical artefact. Clin. Chem. 35, 1891-1896 (1989).
27. Brent GA. Maternal thyroid function: interpretation of thyroid function tests in pregnancy. Clin. Obstet. Gynecol. 40, 3-15 (1997).
28. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr. Rev. 18, 404-433 (1997).
29. Mandel SJ, Spencer CA, Hollowell JG. Are detection and treatment of thyroid insufficiency in pregnancy feasible? Thyroid 15, 44-53 (2005).
30. Roti E, Gardini E, Minelli R, Bianconi L, Flisi M. Thyroid function evaluation by different commercially available free thyroid hormone measurement kits in term pregnant women and their newborns. J. Endocrinol. Invest. 14, 1-9 (1991).
31. Soldin OP. Thyroid function testing in pregnancy and thyroid disease. Trimester-specific reference intervals. Ther. Drug Monit. 28, 8-11 (2006).
32. Sapin R, D'Herbomez M, Schlienger JL. Free thyroxine measured with equilibrium dialysis and nine immunoassays decreases in late pregnancy. Clin. Lab. 50, 581-584 (2004).
33. Soldin OP, Tractenberg RE, Hollowell JG, Jonklaas J, Janicic N, Soldin SJ: Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimester in iodine sufficiency. Thyroid 14, 1084-1090 (2004).
34. Dashe JS, Casey BM, Wells CE et al. Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet. Gynecol. 106, 753-757 (2005).
35. Glinoer D, De Nayer P, Delange F et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. J. Clin. Endocrinol. Metab. 80, 258-269 (1995).
36. Pedersen KM, Laurberg P, Iversen E et al. Amelioration of some pregnancy-associated variations in thyroid function induced by iodine supplementation. J. Clin. Endocrinol. Metab. 77, 1078-1083 (1993).
37. Romano R, Jannini EA, Pepe M et al. The effects of iodoprophylaxis on thyroid size during pregnancy. Am. J. Obstet. Gynecol. 164, 482-485 (1991).
38. Liesenkötter KP, Göpel W, Bogner U, Stach B, Grüters A. Earliest prevention of endemic goiter by iodine supplementation during pregnancy. Eur. J. Endocrinol. 134, 443-448 (1996).
39. Hollowell JG, Staehling NW, Hannon WH et al. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994). J. Clin. Endocrinol. Metab. 83, 3401-3408 (1998).
40. WHO; technical consultation of experts in Geneva in January 2005. The prevention and control of ID in pregnant and lactating women and in children under two years: recommendations of a WHO Technical Consultation. Public Health Nutr. (2008) (In press).
41. Caron P, Hoff M, Bazzi S et al. Urinary iodine excretion during normal pregnancy in healthy women living in the southwest of France: correlation with maternal thyroid parameters. Thyroid 7, 749-754 (1997).
42. Sack J, Goldstein A, Charpak N et al. Postpartum maternal hyperthyrotropinemia in an area in which iodine supplementation is required. Thyroid 13, 959-964 (2003).
43. Glinoer D, Rihi M, Grun JP, Kinthaert J. Risk of sublinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J. Clin. Endocrinol. Metab. 79, 197-204 (1994).
44. Othman S, Phillips DI, Parkes AB et al. A long-term follow-up of postpartum thyroiditis. Clin. Endocrinol. (Oxford). 32, 559-564 (1990).
45. Premawardhana LD, Parkes AB, Ammari F et al. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J. Clin. Endocrinol. Metab. 85, 71-75 (2000).
46. Poppe K, Glinoer D. Thyroid autoimmunity and hypothyroidism before and during pregnancy. Hum. Reprod. 9, 149-161 (2003).
47. Poppe K, Glinoer D, Van Steirteghem A et al. Thyroid dysfunction and autoimmunity in infertile women. Thyroid 12, 997-1001 (2002).
48. Poppe K, Glinoer D, Tournaye H et al. Assisted reproduction and thyroid immunity: an unfortunate combination? J. Clin. Endocrinol. Metab. 88, 4149-4152 (2003).
49. Prummel MF, Wiersinga WM. Thyroid autoimmunity and miscarriage. Eur. J. Endocrinol. 150, 751-755 (2004).
50. Roberts J, Jenkins C, Wilson R et al. Recurrent miscarriage is associated with increased numbers of CD5/20 positive lymphocytes and an increased incidence of thyroid antibodies. Eur. J. Endocrinol. 134, 84-86 (1996).
51. Matalon ST, Blank M, Ornoy A, Shoenfeld Y. The association between anti-thyroid antibodies and pregnancy loss. Am. J. Reprod. Immunol. 45, 72-77 (2001).
52. Negro R, Formoso G, Coppola L et al. Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: the role of autoimmunity and thyroid function. J. Endocrinol. Invest. 30, 3-8 (2007).
53. Baker VL, Rone HM, Pasta DJ, Nelson HP, Gvakharia M, Adamson GD. Correlation of thyroid stimulating hormone (TSH) level with pregnancy outcome in woman undergoing in vitro fertilization. Am. J. Obstet. Gynecol. 194, 1668-1674 (2006).
54. Negro R, Mangieri T, Coppola L et al. Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Hum. Reprod. 20, 1529-1533 (2005).
55. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J. Clin. Endocrinol. Metab. 91, 2587-2591 (2006).
56. Haddow JE, Palomaki GE, Allan WC et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsycological development of the child. N. Engl. J. Med. 34, 549-555 (1999).
57. Pop VJ, Kuijpens JL, van Baar AL et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin. Endocrinol. (Oxford) 50, 147-148 (1999).
58. Pop VJ, Brouwers EP, Vader HL Vulsma T, van Baar AL, de Vijlder JJ. Maternal hypothyroxinemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin. Endocrinol. (Oxford) 59, 282-288 (2003).
59. Vermiglio F, Lo Presti VP, Moleti M et al. Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency disorder in developed countries. J. Clin. Endocrinol. Metab. 89, 6054-6060 (2004).
60. Kooistra L, Crawford S, van Baar AL, Brouwers EP, Pop VJ. Neonatal effects of maternal hypothyroxinemia during early pregnancy. Pediatrics 117, 161-167 (2006)
61. Calvo RM, Jauniax E, Gulbis B et al. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J. Clin. Endocrinol. Metab. 87, 1768-1777 (2002).
62. Auso E, Lavado-Autric R, Cuevas E, Escobar del Rey F, Morreale de Escobar G, Berbel P. A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 145, 4037-4047 (2004).
63. Wasserman EE, Nelson K, Rose NR et al. Maternal thyroid autoantibodies during the third trimester and hearing deficits in children: an epidemiologic assessment. Am. J. Epidemiol. (2007).
64. Casey BM, Dashe JS, Spong CY, McIntire DD, Leveno KJ, Cunningham GF. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet. Gynecol. 109, 1129-1135 (2007).
65. Wilson JMG, Jungner G. Principles and practice of screening for disease. WHO Chronicle 22, 473 (1968).
66. American Academy of Pediatrics, Section on Endocrinology and Committee on Genetics; American Thyroid Association, Committee on Public Health. Newborn screening for congenital hypothyroidism: recommended guidelines. Pediatrics 92, 1203-1209 (1993).
67. Vaidya B, Anthony S, Bilous M et al. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J. Clin. Endocrinol. Metab. 92, 203-207 (2007).
68. Demers LM, Spencer CA. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin. Endocrinol. (Oxford) 58, 138-140 (2003).
69. Vaidya B, Bilous M, Hutchinson RS et al. Screening for thyroid disease in pregnancy: an audit. Clin. Med. 2, 599-600 (2002).
70. Power ML, Kilpatrick S, Schulkin J. Diagnosing and managing thyroid disorders during pregnancy: a survey of obstetrician-gynecologists. J. Reprod. Med. 49, 79-82 (2004).
71. Haddow JE, McClain, MR, Palomaki GE, Kloza EM, Williams J. Screening for thyroid disorders during pregnancy: results of a survey in Maine. Am. J. Obstet. Gynecol. 194, 471-474 (2006).